205 related articles for article (PubMed ID: 25415351)
1. Preclinical evaluation of antitumor activity of acid-sensitive PEGylated doxorubicin.
Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
ACS Appl Mater Interfaces; 2014 Dec; 6(23):21202-14. PubMed ID: 25415351
[TBL] [Abstract][Full Text] [Related]
2. pH-Responsive Reversible PEGylation Improves Performance of Antineoplastic Agent.
Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
Adv Healthc Mater; 2015 Apr; 4(6):844-55. PubMed ID: 25645303
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
[TBL] [Abstract][Full Text] [Related]
4. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
5. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
Cui C; Xue YN; Wu M; Zhang Y; Yu P; Liu L; Zhuo RX; Huang SW
Biomaterials; 2013 May; 34(15):3858-69. PubMed ID: 23452389
[TBL] [Abstract][Full Text] [Related]
8. Selective intracellular drug delivery from pH-responsive polyion complex micelle for enhanced malignancy suppression in vivo.
Wang J; Xu W; Guo H; Ding J; Chen J; Guan J; Wang C
Colloids Surf B Biointerfaces; 2015 Nov; 135():283-290. PubMed ID: 26277711
[TBL] [Abstract][Full Text] [Related]
9. Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery.
Cao J; Su T; Zhang L; Liu R; Wang G; He B; Gu Z
Int J Pharm; 2014 Aug; 471(1-2):28-36. PubMed ID: 24836667
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
11. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.
Deng H; Liu J; Zhao X; Zhang Y; Liu J; Xu S; Deng L; Dong A; Zhang J
Biomacromolecules; 2014 Nov; 15(11):4281-92. PubMed ID: 25325531
[TBL] [Abstract][Full Text] [Related]
12. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
[TBL] [Abstract][Full Text] [Related]
13. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
[TBL] [Abstract][Full Text] [Related]
14. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of monomethoxy poly(ethylene glycol)-poly (ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma.
Zheng L; Gou M; Zhou S; Yi T; Zhong Q; Li Z; He X; Chen X; Zhou L; Wei Y; Qian Z; Zhao X
Oncol Rep; 2011 Jun; 25(6):1557-64. PubMed ID: 21455590
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
17. MPEG-DSPE polymeric micelle for translymphatic chemotherapy of lymph node metastasis.
Li X; Dong Q; Yan Z; Lu W; Feng L; Xie C; Xie Z; Su B; Liu M
Int J Pharm; 2015 Jun; 487(1-2):8-16. PubMed ID: 25841567
[TBL] [Abstract][Full Text] [Related]
18. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
19. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles.
Gou M; Shi H; Guo G; Men K; Zhang J; Zheng L; Li Z; Luo F; Qian Z; Zhao X; Wei Y
Nanotechnology; 2011 Mar; 22(9):095102. PubMed ID: 21270494
[TBL] [Abstract][Full Text] [Related]
20. Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.
Li N; Lu W; Yu J; Xiao Y; Liu S; Gan L; Huang J
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():179-189. PubMed ID: 30033244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]